Drug Watch: Drugs for GI disorders.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 536
- Publication type:
- Article
Works matching IS 1082801X AND DT 1999 AND VI 34 AND IP 6
Results: 18
1
2
FDA's pediatric labeling initiatives seek to end children's 'therapeutic orphan' status.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 534
- By:
- Publication type:
- Article
3
Standardized erythropoietin dosing and transfusion guidelines appear helpful in anemia of prematurity.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 531
- Publication type:
- Article
4
NSAID use in nursing home: Pharmacist interventions reduce costs, morbidities.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 531
- Publication type:
- Article
5
Adding herbals to a health care benefit package: Which products to consider.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 530
- Publication type:
- Article
6
Using drug-use alerts, prior authorization, and patient profiling to improve drug use.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 529
- Publication type:
- Article
7
Balancing clinical, cost, and satisfaction outcomes a key to physician-led MCO strategies.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 525
- Publication type:
- Article
8
Tips on avoiding liability issues associated with coverage of herbal products.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 525
- Publication type:
- Article
9
Most California hospitals losing money on Medicare capitation.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 525
- Publication type:
- Article
10
Using decision analysis to evaluate the cost effectiveness of GP IIb/IIIa antagonists.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 515
- By:
- Publication type:
- Article
11
GP IIb/IIIa receptor inhibitors: Clinical and cost considerations in acute coronary syndromes.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 500
- By:
- Publication type:
- Article
12
Rivastigmine: An acetylcholinesterase inhibitor for patients with Alzheimer's disease.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 493
- By:
- Publication type:
- Article
13
News in brief.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 492
- Publication type:
- Article
14
Ipratropium lowers overall COPD treatment costs compared with albuterol.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 492
- Publication type:
- Article
15
NMDA blocker is first drug to improve functional ability in severe dementia.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 491
- Publication type:
- Article
16
Nonsedating antihistamine curbs allergy symptoms at least as well as market leader loratadine.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 488
- Publication type:
- Article
17
Preoperative intranasal mupirocin lowers risk of nosocomial S aureus infections.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 488
- Publication type:
- Article
18
FDA drug approvals.
- Published in:
- Formulary, 1999, v. 34, n. 6, p. 480
- Publication type:
- Article